These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5114498)

  • 1. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of monamine oxidase inhibitors on qualitive alterations ( Transformation ) of the catalytic properties of amine oxidases.
    Gorkin VZ; Akopyan ZI; Veryovkina IV; Stesina LN; Samed MM
    Biochem J; 1971 Feb; 121(3):31P-32P. PubMed ID: 5000918
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitochondrial monoamine oxidase of rat liver: reversible qualitative alterations in catalytic properties.
    Veryovkina IV; Samed MM; Gorkin VZ
    Biochim Biophys Acta; 1972 Jan; 258(1):56-70. PubMed ID: 5058405
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 7. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoamine oxidase and adenylate deaminase activity of mitochondrial fractions of the rat liver in alcoholic intoxication].
    Isakhanian GD; Gorkin VZ
    Vopr Med Khim; 1976; 22(1):76-81. PubMed ID: 829006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of betahistine in the rat.
    Sternson LA; Tobia AJ; Walsh GM; Sternson AW
    Drug Metab Dispos; 1974; 2(2):123-8. PubMed ID: 4150992
    [No Abstract]   [Full Text] [Related]  

  • 12. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.
    Parkinson D; Callingham BA
    J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
    Horita A
    Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 15. Deamination of biogenic amines and other nitrogenous compounds in granulation tissue from experimental wounds.
    Romanova LA; Stalnaya ID; Gorkin VZ
    Med Biol; 1975 Aug; 53(4):205-9. PubMed ID: 1186318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the chromatographic purification and some properties of rat mitochondrial monoamine oxidase].
    Kliashtorin LB; Gridneva LI; Gorkin VZ
    Biokhimiia; 1966; 31(1):167-73. PubMed ID: 5982386
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
    Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
    Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
    [No Abstract]   [Full Text] [Related]  

  • 19. Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):27-42. PubMed ID: 4260803
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.